State Public Policy Initiatives

HB300/SB177 will require most health insurers to cover supplemental and diagnostic breast imaging (mammograms, MRIs and ultrasounds) with no patient cost-sharing. 

HB40/SB19 will require most health insurers to cover prostate cancer screening for men at increased risk with no copay, deductible or coinsurance.

HB293 will establish a state Genetic Counseling Advisory Council and licensure of qualified genetic counselors within the state.

HB148 will expand the current law covering supplemental and diagnostic breast imaging, adding biopsy and consultation to the list of services covered with no patient cost-sharing.

SB1347 will require most health plans to cover fertility preservation for individuals who will encounter medically-induced infertility due to cancer treatment.

HB2617 will require most health insurers to cover prostate cancer screening for men age 50 or older, and those at increased risk of cancer, before age 50, with no copay, deductible or coinsurance.

SB1165 will require most health insurers to cover guideline-recommended breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing. 

HB4010 will facilitate state licensure of genetic counselors by the American Board of Genetic Counseling (ABGC). 

AB1570 will require most health insurers to cover supplemental and diagnostic breast imaging (mammograms, MRIs and ultrasounds) with no patient cost-sharing based on National Comprehensive Cancer Network (NCCN) guidelines. 

B26-0486 will expand the fertility services provided under existing law to include oocyte cryopreservation (storage) for 10 years.

HB1339/SB1372 will require most health insurers to cover genetic testing for those with a personal or family history of cancer, and coverage of the associated NCCN guideline-recommended cancer screenings with no patient cost-sharing. 

HB137 will require the state Medicaid program to cover a mammogram and one (1) supplemental breast screening each year for women ages 25-40 who are at increased risk of cancer (subject to the availability of funds).

SB1494 will expand the existing state law, requiring most major health plans to cover NCCN guideline-recommended high-risk breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing “for an appropriate additional premium.”

HB589 will extend coverage of fertility services, including preservation and IVF, to qualified Medicaid recipients.

HB420 will require most health insurers to cover genetic testing for those with a personal or family history of cancer, and coverage of the associated guideline-recommended cancer screenings with no patient cost-sharing. 

HB588 will expand the current law to include at least three (3) egg retrievals with unlimited embryo transfers in accordance with the American Society for Reproductive Medicine or a comparable organization’s guidelines.

HB2366 will require most health insurers to cover supplemental breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing. 

HB1864/SB2899 will require most health plans to cover fertility preservation for patients, including children under the age of 26, who may become infertile due to medically necessary cancer-related treatment. 

SB717 will require the state's Medicaid program to cover treatments for perimenopause and menopause without imposing step therapy requirements.

HB4897/SB2799 will prohibit life, long-term care and disability insurers from using genetic information when considering benefits, fees or coverage determinations.

HB3001/HB1102 will require most health insurers to cover screening and surveillance tests for ovarian cancer (i.e., ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood tests) for individuals who are at increased risk. 

HB3605 will amend current law by removing the $50 copay for genetic testing and eliminating patient cost-sharing for NCCN guideline-recommended high-risk, supplemental cancer screenings.

HB1112 will require that most health insurers cover supplemental and diagnostic breast imaging (mammograms, MRIs and ultrasounds) with no patient cost-sharing for certain women at increased risk of breast cancer. 

HF2258/SF130 will require most health insurers to provide coverage for the diagnosis and treatment of infertility, including standard fertility preservation services and IVF.

SB409 will expand the existing state law, requiring most major health plans to cover supplemental breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing.

HB20 will require most health insurers to cover at least two (2) cycles of in vitro fertilization (IVF), intrauterine insemination, and any other process using assisted reproductive technology.

HB135 will revise the current statute, expanding coverage of supplemental and diagnostic breast imaging (mammograms, MRIs and ultrasounds) with no patient cost-sharing to include short-term, limited-duration and student health insurance plans.

SB84 will require most health insurers to cover NCCN guideline-recommended prostate cancer screening for men at increased risk with no copay, deductible or coinsurance.

H5112 will prohibit life, long-term care and disability insurers from using genetic information when considering benefits, fees or coverage determinations.

H4551 will expand coverage of fertility services by most commercial health plans to include preimplantation genetic testing (PGT/D).

HD4994/S788 will revise the current law, expanding coverage of medically appropriate breast screenings (breast mammograms, MRIs and ultrasounds) and diagnostic imaging with no patient cost-sharing to include active or retired state employees.

H4554 will expand the current law to require most insurers and Medicaid to cover fertility preservation for individuals who need treatment or have a condition that may impair their fertility by surgery, radiation, chemotherapy, or other medical treatment.

HB5205 will require most health insurers to cover guideline-recommended breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing. 

SB717 will require Medicaid to cover menopause and perimenopause treatment, including FDA-approved drugs, without imposing step-therapy protocols.

HF703/SF1302 will require most health insurers to cover genetic testing for those with a personal or family history of cancer, and coverage of the associated NCCN guideline-recommended cancer screenings with no patient cost-sharing. 

HF1758/SF1961 will facilitate Medicaid and private/commercial insurance coverage of the diagnosis and treatment of infertility, including fertility preservation and IVF.

SB2120 will require most health insurers to cover annual prostate cancer screening for men at increased risk of cancer, ages 40-49, and men age 50 or older at average-risk of cancer, with no copay, deductible or coinsurance.

SB2121 will facilitate insurance coverage of fertility preservation services for individuals who undergo a medically necessary treatment that may cause medically-induced (iatrogenic) infertility.

HB2635 will require the state Medicaid program to cover the diagnosis and treatment of infertility, including IVF.

HB3244/SB900 will require individual and group health plans (with 25 or more employees) to cover the diagnosis and treatment of infertility, including IVF.

HB1879/SB1113 will require most health insurers to cover genetic counseling and multigene panel genetic testing for individuals assessed to be at an increased risk, with no patient cost-sharing. 

LB338 will prohibit life, long-term care and disability insurers from using genetic information when considering benefits, fees or coverage determinations.

LB233 will require Nebraska State Employee Insurance Programs to cover in-vitro fertilization (IVF).

A1142/S1796 will require most group health plans to cover prostate cancer screening for men over age 50, and men ages 40-49 with a family history of prostate cancer or other high-risk factors, with no copay, deductible or coinsurance.

S1275 will require most health insurers to cover NCCN guideline-recommended breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing. 

S1770 will require insurance plans that provide pregnancy-related benefits to also cover preimplantation genetic testing (PGT/D) and in-vitro fertilization (IVF), for the purpose of preventing certain serious genetic conditions from being passed on to offspring.

S327 will require most health insurers to cover medically necessary screening for ovarian cancer for symptomatic women or women at risk of ovarian cancer, including annual pelvic exam, ultrasound and blood testing for cancer markers.

S3006 will facilitate Medicaid coverage of fertility preservation services for individuals facing infertility caused by medically necessary surgery or treatments.

A6561/S6551 will modify current statute to require coverage of image-guided breast biopsies, with patient cost-sharing.

A5444 will require most health insurers to cover perimenopausal/menopausal care and treatment administered by a physician or other licensed healthcare provider with no patient cost-sharing.

S3745 will require most health insurance plans and Medicaid to cover fertility preservation when medically necessary cancer-related surgery or treatment may cause infertility.

A183/S3029 will establish a state board for genetic counseling and licensure of genetic counselors. 

A3229/S6124 will prohibit life, long-term care and disability insurers from using genetic information when considering benefits, fees or coverage determinations. 

H297/S553 will require most health insurers to cover high-risk/supplemental breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing. 

SB668/HB697 will establish a state Genetic Counselors Licensure Board and licensure of qualified genetic counselors within the state.

HB635 will require large group health plans to cover the diagnosis and treatment of infertility, including up to three (3) in-vitro fertilization (IVF) cycles.

HB271 makes changes to the current statute, adding diagnostic breast imaging, in addition to supplemental breast cancer screening, without patient cost-sharing. Also adds Medicaid to the insurers covered by the law.

HB33 will require private/commercial health insurers to cover prostate screenings with no patient cost-sharing for individuals at increased risk.

HB4155 will require most health plans to cover fertility preservation and IVF.

HB1530 would require direct-to-consumer genetic testing companies to obtain the consumer's express consent before sharing genetic data with an employer or an entity offering health insurance, life insurance or long-term care insurance. 

HB1179 would require organizations that handle genetic material to explain how it’s used, get consent before sharing it, ban sharing with insurers, employers, or government agencies without proper authorization, and implement employee privacy training.

SB351 will require most health plans to cover in vitro fertilization (IVF).

SB535/SB536 will enable genetic counselors to order medically appropriate genetic tests and other diagnostic studies.

HB281/SB447 will require most health insurers to cover prostate cancer screening with no cost-sharing for individuals at increased risk.

SB1122 will require most health insurers to cover treatments for the management of menopause, including behavioral therapy. Patient cost-sharing (copay, coinsurance and deductibles) applies.

HB7276/S2032 will require that most health insurers cover supplemental breast screenings (mammograms, MRIs and ultrasounds) for individuals at increased risk of breast cancer and diagnostic imaging with no patient cost-sharing. 

H3202/S820 will require most health insurers to cover guideline-recommended breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing. 

H2357 will prohibit life, long-term care and disability insurers from using genetic information when considering benefits, fees or coverage determinations.

HB1775/SB1626 will require most health insurers to cover genetic testing for those with a personal or family history of cancer, and coverage of the associated guideline-recommended cancer screenings with no patient cost-sharing. 

H302 will facilitate private/commercial insurance coverage of fertility preservation and IVF; requests CMS approval to cover these services for Medicaid recipients.

HB328 will make the diagnosis and treatment of infertility, including fertility preservation and in-vitro fertilization (IVF), essential health benefits, requiring coverage by most health plans in the state.

SB6202 would require Medicaid coverage of fertility preservation for patients undergoing medical treatments that may leave them infertile.

HB1129/SB5121 will facilitate private/group health insurance and Medicaid coverage of fertility preservation.

SB518 will require most health insurers to cover supplemental breast screenings (breast MRIs, diagnostic mammograms, and breast ultrasounds) and diagnostic imaging with no patient cost-sharing based on NCCN or other professional guidelines. 

SB107 will require most health insurers to cover fertility preservation and treatment for individuals who are or may become infertile due to therapy or surgery.

AB263/SB264 will require that most health insurers, including Medicaid, cover supplemental and diagnostic breast imaging with no patient cost-sharing.